Maiken Keson-Brookes
Net worth: 224 974 $ as of 2024-03-30
Profile
Ms. Maiken Keson-Brookes is a Secretary & Chief Legal Officer at Mural Oncology Plc.
Ms. Keson-Brookes was previously employed as a Secretary & Chief Legal Officer by VL26, INC., a Secretary by Synlogic, Inc., a Senior Vice President & General Counsel by uniQure NV, a Vice President & General Counsel by FORUM Pharmaceuticals, Inc., an Associate General Counsel by Biogen Idec, Inc., and a Secretary & General Counsel by Cxloyalty Inernational Ltd.
She received her graduate degree from King's College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.28% | 2024-02-29 | 46,007 ( 0.28% ) | 224 974 $ | 2024-03-30 |
Maiken Keson-Brookes active positions
| Companies | Position | Start |
|---|
Former positions of Maiken Keson-Brookes
| Companies | Position | End |
|---|---|---|
| RUBIUS THERAPEUTICS | General Counsel | 2022-11-14 |
| UNIQURE N.V. | General Counsel | 2017-06-30 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | General Counsel | 2016-05-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2008-12-31 |
| SYNLOGIC, INC. | General Counsel | 2019-10-31 |
Training of Maiken Keson-Brookes
| King's College London | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| UNIQURE N.V. | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| Private companies | 3 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Cxloyalty Inernational Ltd.
 Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Maiken Keson-Brookes
